The good and the bad of synoptic radiology reports

Synoptic radiology reports with detailed information on disease sites in ovarian cancer could help to guide surgical decisions, but they can come at a cost, according to new data in the American Journal of Roentgenology

Structured reports simplify radiologists’ interpretation processes, but synoptic reports offer greater detail on the presence or absence of disease, which can be beneficial in surgical planning. However, there is a caveat—despite their added value for surgeons, synoptic reports significantly increase radiologists’ report turnaround times. 

In a new AJR study, experts compared hundreds of contrast-enhanced abdominopelvic CT scans and their accompanying reports for patients with advanced ovarian cancer. Of those, 128 were structured, while 77 were done in a synoptic format that included a list of 45 anatomic sites relevant to ovarian cancer management, each classified in terms of disease absence versus presence. 

Mean report turnaround times rose significantly when the synoptic format was used, increasing from 29.8 minutes for simple structured reports to 54.5 minutes.  

However, synoptic reports offered providers much more information; for example, structured reports mentioned just 17.6 out of 45 anatomic sites on average versus 44.5/45 sites for synoptic reports. Additionally, involvement of anatomic sites with surgically unresectable or challenging-to-resect disease were mentioned in just 37% of structured reports but were highlighted in 100% of synoptic reports. 

Corresponding author of the new paper Pamela Causa Andrieu, MD, from the Department of Radiology at Memorial Sloan Kettering Cancer Center in New York, and colleagues indicated that such reports detailing the complexity of disease can facilitate improved ovarian cancer treatment planning. 

“The findings indicate the role of disease-specific synoptic reports to facilitate referrer communication and potentially guide clinical decision-making,” the group concluded. 

The study abstract is available here

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.